Preliminary experiments indicate conolidine might inhibit certain ion channels, decreasing neuronal excitability and limiting agony signals. This system is particularly related in neuropathic discomfort, where abnormal signaling will cause persistent discomfort. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathw